These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31457000)

  • 1. Telemedicine in Resource-Limited Settings to Optimize Care for Multidrug-Resistant Tuberculosis.
    Huang GKL; Pawape G; Taune M; Hiasihri S; Ustero P; O'Brien DP; du Cros P; Graham S; Wootton R; Majumdar SS
    Front Public Health; 2019; 7():222. PubMed ID: 31457000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
    Guglielmetti L; Jaffré J; Bernard C; Brossier F; El Helali N; Chadelat K; Thouvenin G; Dautzenberg B; Henry B; Jaspard M; Guillot H; Pourcher V; Le Dû D; Marigot-Outtandy D; Mougari F; Raskine L; Rivoire B; Andrejak C; Jarlier V; Aubry A; Robert J; Frechet-Jachym M; Veziris N
    Int J Tuberc Lung Dis; 2019 Oct; 23(10):1050-1054. PubMed ID: 31627768
    [No Abstract]   [Full Text] [Related]  

  • 3. The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017.
    Morris L; Hiasihri S; Chan G; Honjepari A; Tugo O; Taune M; Aia P; Dakulala P; Majumdar SS
    Public Health Action; 2019 Sep; 9(Suppl 1):S4-S11. PubMed ID: 31580333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful implementation of bedaquiline for multidrug-resistant TB treatment in remote Papua New Guinea.
    Taune M; Ustero P; Hiashiri S; Huang K; Aia P; Morris L; Main S; Chan G; du Cros P; Majumdar SS
    Public Health Action; 2019 Sep; 9(Suppl 1):S73-S79. PubMed ID: 31579654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
    Dheda K; Cox H; Esmail A; Wasserman S; Chang KC; Lange C
    Respirology; 2018 Jan; 23(1):36-45. PubMed ID: 28850767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea.
    Bainomugisa A; Lavu E; Pandey S; Majumdar S; Banamu J; Coulter C; Marais B; Coin L; Graham SM; du Cros P
    BMC Infect Dis; 2022 May; 22(1):437. PubMed ID: 35524232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
    Guglielmetti L; Ardizzoni E; Atger M; Baudin E; Berikova E; Bonnet M; Chang E; Cloez S; Coit JM; Cox V; de Jong BC; Delifer C; Do JM; Tozzi DDS; Ducher V; Ferlazzo G; Gouillou M; Khan A; Khan U; Lachenal N; LaHood AN; Lecca L; Mazmanian M; McIlleron H; Moschioni M; O'Brien K; Okunbor O; Oyewusi L; Panda S; Patil SB; Phillips PPJ; Pichon L; Rupasinghe P; Rich ML; Saluhuddin N; Seung KJ; Tamirat M; Trippa L; Cellamare M; Velásquez GE; Wasserman S; Zimetbaum PJ; Varaine F; Mitnick CD
    Trials; 2021 Sep; 22(1):651. PubMed ID: 34563240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda.
    Baluku JB; Katuramu R; Naloka J; Kizito E; Nabwana M; Bongomin F
    BMC Pulm Med; 2021 Jul; 21(1):220. PubMed ID: 34246234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid.
    Pecora F; Dal Canto G; Veronese P; Esposito S
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34067732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-drug resistant tuberculosis burden and risk factors: an update.
    Marahatta SB
    Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.